Zura Bio Earnings Estimate

ZURA Stock   6.08  0.13  2.09%   
The next projected EPS of Zura Bio is estimated to be -0.155 with future projections ranging from a low of -0.155 to a high of -0.155. Zura Bio's most recent 12-month trailing earnings per share (EPS TTM) is at -0.65. Please be aware that the consensus of earnings estimates for Zura Bio Limited is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
 
Interest Hikes
Zura Bio is projected to generate -0.155 in earnings per share on the 31st of December 2025. Zura Bio earnings estimates show analyst consensus about projected Zura Bio Limited EPS (Earning Per Share). It derives the highest and the lowest estimates based on Zura Bio's historical volatility. Many public companies, such as Zura Bio, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Zura Bio's earnings estimates, investors can diagnose different trends across Zura Bio's analyst sentiment over time as well as compare current estimates against different timeframes. As of February 15, 2026, Gross Profit is expected to decline to -8,505Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zura Bio Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Zura Bio Earnings Estimation Breakdown

The calculation of Zura Bio's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Zura Bio is estimated to be -0.155 with the future projection ranging from a low of -0.155 to a high of -0.155. Please be aware that this consensus of annual earnings estimates for Zura Bio Limited is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-0.17
-0.15
Lowest
Expected EPS
-0.155
-0.15
Highest

Zura Bio Earnings Projection Consensus

Suppose the current estimates of Zura Bio's value are higher than the current market price of the Zura Bio stock. In this case, investors may conclude that Zura Bio is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Zura Bio's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2025Current EPS (TTM)
628.97%
-0.17
-0.155
-0.65

Zura Bio Earnings per Share Projection vs Actual

Actual Earning per Share of Zura Bio refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Zura Bio Limited predict the company's earnings will be in the future. The higher the earnings per share of Zura Bio, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Zura Bio Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Zura Bio, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Zura Bio should always be considered in relation to other companies to make a more educated investment decision.

Zura Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Zura Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-11-13
2025-09-30-0.31-0.170.1445 
2025-08-14
2025-06-30-0.3-0.170.1343 
2025-05-08
2025-03-31-0.29-0.190.134 
2025-03-25
2024-12-31-0.24-0.10.1458 
2024-11-07
2024-09-30-0.13-0.26-0.13100 
2024-08-13
2024-06-30-0.15-0.17-0.0213 
2024-05-09
2024-03-31-0.23-0.020.2191 
2024-03-28
2023-12-31-0.23-0.190.0417 
2023-11-13
2023-09-30-0.25-0.180.0728 
2023-08-14
2023-06-30-0.25-1.31-1.06424 
2023-03-28
2022-12-3100.040.04
null
nullnullnullnull

About Zura Bio Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Zura Bio earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Zura Bio estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Zura Bio fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-140.3 M-133.3 M
Earnings Yield(0.32)(0.34)
Price Earnings Ratio(4.12)(3.91)
Price Earnings To Growth Ratio 0.06  0.06 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Zura Bio Limited offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zura Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zura Bio Limited Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zura Bio Limited Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zura Bio Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zura Bio. Anticipated expansion of Zura directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Zura Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.65)
Return On Assets
(0.27)
Return On Equity
(0.45)
Understanding Zura Bio Limited requires distinguishing between market price and book value, where the latter reflects Zura's accounting equity. The concept of intrinsic value - what Zura Bio's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Zura Bio's price substantially above or below its fundamental value.
Please note, there is a significant difference between Zura Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zura Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Zura Bio's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.